Rapport Therapeutics, Inc. RAPP Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s common stock?
- Rapport Therapeutics, Inc. (RAPP) reported common stock of $48K in Q1 2026.
- How has Rapport Therapeutics, Inc.'s common stock changed year-over-year?
- Rapport Therapeutics, Inc.'s common stock increased by 29.7% year-over-year, from $37K to $48K.
- What is the long-term trend for Rapport Therapeutics, Inc.'s common stock?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s common stock has grown at a 246.4% compound annual growth rate (CAGR), from $4K to $48K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).